IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes by Pennino, Davide et al.
                      
                            
              
                                                                       
                                                                             


































































                      






















                      
                                                      






















                                                      
     
     
      
            
    
            
        
 
 
    
 
         
 
  
            
 
